Endotoxin Testing and RMMs - How to Improve Manufacturing Agility and Increase Efficiency

[Article Title]

Time matters. Everyone in pharmaceutical manufacturing is busy, making it imperative to find better monitoring tools. In particular, bioburden monitoring and bacterial endotoxin testing (BET) are areas in need of improvement. These contaminants are high risk in any pharmaceutical manufacturing site and should be monitored as quickly and easily as possible. However, these tests are traditionally time-consuming and require significant hands-on time.

Download Document

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.